News
BOSTON, MA, USA I May 19, 2025 I Medera Inc. (“Medera”), a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback